Upper Extremity Training for Chronic Cervical Spinal Cord Injury
NCT ID: NCT04921592
Last Updated: 2025-05-06
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
36 participants
INTERVENTIONAL
2021-06-14
2027-11-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Combining Spinal Cord Transcutaneous Stimulation and Activity-based Training in Inpatient Rehabilitation to Facilitate Upper Limb Function of Individuals with Acute to Subacute Cervical Spinal Cord Injury
NCT06773286
Activity-Based Therapy and Transcutaneous Spinal Cord Stimulation After Spinal Cord Injury (ABT-TCSCS)
NCT06472986
MEP Up-conditioning to Target Corticospinal Plasticity
NCT06989905
Rebuilding Inter-limb Transfer in Cervical SCI
NCT06440538
Noninvasive Spinal Stimulation to Restore Hand Function in Children with Spinal Cord Injury
NCT06489106
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
i) Physical evaluation by the clinician or physician including the Classification of Spinal Cord Injury (ISNCSCI exam. ii) A series of tests to evaluate the trunk, arm function with and without using tests to evaluate muscle activation. iii) A series of questionnaires to evaluate function and quality of life iv) Two separate Magnetic Resonance Imaging (MRI) of spinal column (head to hip).
Randomized to one of three groups:
Group 1: will be upper extremity training with transcutaneous spinal stimulation of the spine combined with upper extremity and trunk rehabilitation. The group will complete 60 training sessions transcutaneous spinal stimulation.
Group 2: will be upper extremity training with transcutaneous spinal stimulation of the spine combined with upper extremity and trunk rehabilitation. The group will complete 40 training sessions of transcutaneous spinal stimulation. The group will then complete 20 sessions of rehabilitation therapy of the upper extremities and trunk (no stimulation).
Group 3: will be will be upper extremity training with transcutaneous spinal stimulation of the spine combined with upper extremity and trunk rehabilitation. The group will complete 20 training sessions of transcutaneous spinal stimulation. The group will then complete 40 sessions of rehabilitation therapy of the upper extremities and trunk (no stimulation).
Transcutaneous spinal stimulation will involve stimulating the spinal segments between C5/6 to lumber regions. Training time will be approximately 1 hour, 3-4 times per week.
Rehabilitation therapy will involve exercises concentrating on fingers, hand, arm and trunk function. A physical therapist will be at training and testing sessions.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
transcutaneous stimulation
1. transcutaneous stimulation 60 sessions
2. Transcutaneous stimulation 40sessions
3. Transcutaneous stimulation 20 sessions
upper extremity stimulation
transcutaneous stimulation of the upper extremities
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
upper extremity stimulation
transcutaneous stimulation of the upper extremities
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* spinal cord injury for greater than or equal to 6 months.
* spinal cord injury at a cervical neurologic level of injury.
Exclusion Criteria
* history of fractures.
* pressure sore or skin issues.
* history of illicit drug abuse.
* history of cardiac, respiratory, bladder, renal or other medical disorder unrelated to spinal cord injury.
* bladder Botox injections less than 12 months prior.
* muscle Botox injections less than 12 months prior.
* colostomy bag or urostomy.
* implanted pump (i.e., baclofen pump, pain pump, etc).
* If I am female: I am pregnant at the time of enrollment or planning to become pregnant during the course of the study.
* unable to wean from anti-spasticity medication.
* contraindications to MRI imaging (pacemaker, metallic foreign body, aneurysm clip, etc.)
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Kessler Foundation
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Gail Forrest
Director, Center for Spinal Stimulation
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Gail F Forrest, PhD
Role: PRINCIPAL_INVESTIGATOR
Kessler Foundation
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Kessler Foundation
West Orange, New Jersey, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
R-1153-21
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.